Long-term Efficacy and Safety of Fluticasone Propionate Powder Administered Once or Twice Daily via Inhaler to Patients With Moderate Asthma
- 1 August 2000
- Vol. 118 (2) , 303-312
- https://doi.org/10.1378/chest.118.2.303
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Administration of budesonide once daily by means of Turbuhaler to subjects with stable asthmaJournal of Allergy and Clinical Immunology, 1999
- Once-daily budesonide in mild asthmaRespiratory Medicine, 1998
- The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control☆, ☆☆, ★, ★★Journal of Allergy and Clinical Immunology, 1997
- The DiskusTM: A New Multi-Dose Powder Device – Efficacy and Comparison with TurbuhalerTMJournal of Aerosol Medicine, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Binding kinetics of fluticasone propionate to the human glucocorticoid receptorSteroids, 1994
- Evaluation of fluticasone propionate (500 μg day−1) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day−1) administered by pressurized inhalerRespiratory Medicine, 1993
- Structure-activity relationships of topically active steroids: the selection of fluticasone propionateRespiratory Medicine, 1990
- The human pharmacology of fluticasone propionateRespiratory Medicine, 1990
- Failure of once daily inhaled corticosteroid treatment to control chronic asthma.Thorax, 1984